Studies comparing propiverine hydrochloride with newer antimuscarinic agents such as solifenacin succinate for the treatment of overactive bladder (OAB) in Japanese patients have not been performed.
In clinical trials, the combination of Myrbetriq + solifenacin succinate was associated with greater improvements in the number of incontinence episodes per 24 hours (primary endpoint), the number of ...
The FDA has approved Vesicare LS (solifenacin succinate; Astellas Pharma) oral suspension for the treatment of neurogenic detrusor overactivity (NDO) in pediatric patients 2 years of age and older.
According to a new study published in BJU International, solifenacin succinate—an oral antimuscarinic agent—significantly improves quality of life in patients with overactive bladder syndrome. The ...
PISCATAWAY, N.J., May 28, 2019 /PRNewswire/ -- It was a very significant week for Novadoz Pharmaceuticals, the U.S sales & marketing affiliate of The MSN Group (MSN) based in Hyderabad, India. The ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The novel muscarinic M3 receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback